We pride ourselves on contributing to patient empowerment through providing API and pharmaceutical intermediates contract development and manufacturing services (CDMO) for novel drug development. In the past 17 years, we worked with 18 US-based novel drug developers and delivered high quality drug substances and reliable analytical test results to support their important decisions making throughout the development phases. It is also our mission to improve quality of life by making drugs more accessible to patients worldwide. We work with drug product manufacturers by supplying drug substances, pharmaceutical intermediates and excipients for oral and topical dosage formulations, so that more patients can have access to safe and effective drugs at hospitals, clinics and pharmacies.